blue cross blue shield of texas glp 1 coverage MCT2D Does Blue Cross Blue Shield
Description
Although GLP-1 receptor agonists clearly improve cardiometabolic risk factors, they are not approved for the treatment of anemia
WEGOVY semaglutide tablet
GLP-1 receptor agonists in the treatment of type 2 diabetesstate-of-the-art
Its a known, long-term effect of drugs like semaglutide
Medicare Part D does not cover medications prescribed solely for weight loss, although coverage for GLP-1 drugs may expand in 2026
